Our Services
Medical Information
Helpful Resources
Published on: 2/28/2026
Methimazole treats hyperthyroidism but can cause mild effects like rash, nausea, headache, and joint pain, and rarely serious problems such as agranulocytosis and liver injury, with warning signs including fever, sore throat, mouth sores, jaundice, dark urine, severe fatigue, or right upper abdominal pain.
There are several factors to consider, and medically approved next steps include keeping up with thyroid, blood count, and liver tests, not stopping the drug suddenly, and seeking urgent care for the red flag symptoms above, with dose changes or alternative treatments if needed; see complete details below to guide your next steps.
If you've been prescribed methimazole, you're likely being treated for hyperthyroidism — most commonly Graves' disease. Methimazole is one of the most widely used and medically recommended medications to reduce excess thyroid hormone production. For many people, it works well and safely.
But like any medication, methimazole can cause side effects. Understanding why they happen — and what to do next — can help you stay calm, informed, and proactive about your health.
Methimazole is an antithyroid medication. It works by blocking the thyroid gland's ability to produce thyroid hormones (T3 and T4). When you have hyperthyroidism, your body produces too much of these hormones, which can cause:
By reducing hormone production, methimazole helps bring your body back into balance.
Side effects occur for a few main reasons:
Most side effects are mild and manageable. Serious reactions are rare — but important to recognize.
These are generally mild and often improve over time:
Many mild side effects resolve within weeks as your body adjusts.
Though rare, certain reactions require immediate medical attention.
This is one of the most serious potential side effects. It usually occurs within the first 2–3 months of treatment but can happen at any time.
Warning signs:
If you experience these symptoms, stop taking methimazole and contact a doctor immediately. A simple blood test can check your white blood cell count.
The good news: agranulocytosis is rare (estimated in fewer than 1% of patients).
Methimazole can rarely affect liver function.
Watch for:
If these symptoms appear, seek medical care promptly. Blood tests can evaluate liver function.
Inflammation of blood vessels can occur but is extremely uncommon.
Symptoms may include:
This requires specialist evaluation.
When starting methimazole, some people feel temporarily "off." This can happen because:
Regular blood testing helps your doctor adjust the dose appropriately. It often takes several weeks to see full improvement.
Certain factors may increase risk:
That said, most people tolerate methimazole well — especially at lower maintenance doses.
Methimazole is most commonly prescribed for Graves' disease, an autoimmune condition that causes hyperthyroidism.
If you're experiencing unexplained symptoms and want to better understand whether they could be related to Graves' Disease, a free AI-powered symptom checker can help you identify patterns and prepare informed questions for your next doctor's appointment.
This can help you prepare for a more productive conversation with your doctor.
If you're experiencing symptoms while taking methimazole, here's a practical plan:
Most side effects are mild and manageable. Serious complications are rare.
Write down:
This information helps your doctor assess the situation quickly.
Routine monitoring typically includes:
Regular monitoring dramatically reduces the risk of missing serious complications.
These could indicate a serious reaction and require urgent medical evaluation.
Do not delay seeking care for potentially life-threatening symptoms.
Never stop methimazole abruptly without speaking to your doctor unless you are instructed to do so due to serious symptoms.
Stopping suddenly can cause thyroid hormone levels to spike again, potentially leading to:
If methimazole isn't tolerated, doctors may consider:
Your provider will help determine the safest option based on your health history.
It depends on the type:
With proper monitoring, most people continue methimazole safely for 12–18 months or longer, depending on treatment goals.
Methimazole is an effective, widely used treatment for hyperthyroidism and Graves' disease. Most people tolerate it well. While side effects can occur, serious reactions are rare and identifiable with proper monitoring.
Here's what matters most:
If you're unsure whether your symptoms are related to your medication or the underlying condition itself, using a free Graves' Disease symptom checker can help you document your symptoms and have a more informed discussion with your healthcare provider.
Above all, if you experience anything that could be serious or life-threatening, speak to a doctor immediately. Early action makes a major difference in outcomes.
With informed care and proper monitoring, methimazole remains a safe and highly effective option for managing hyperthyroidism.
(References)
* Okada T, Oya Y, Hiroi R. Antithyroid Drugs: The Clinical Implications of Their Side Effects. J Clin Med. 2022 Feb 28;11(5):1257. doi: 10.3390/jcm11051257. PMID: 35261541; PMCID: PMC8900085.
* Ross DS, Burch HB, Cooper DS, et al. 2016 Guidelines of the American Thyroid Association for the Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016 Dec;26(12):1343-1422. doi: 10.1089/thy.2016.0229. Erratum in: Thyroid. 2017 Jan;27(1):141. PMID: 27989568.
* Patel R, Bhansali A, Dhoat N, et al. Drug-induced liver injury secondary to antithyroid drugs: an experience from a tertiary care center in North India. Postgrad Med J. 2019 Jul;95(1125):376-379. doi: 10.1136/postgradmedj-2018-136195. Epub 2018 Dec 25. PMID: 30588691.
* Wang Y, Li Z, Liu B, et al. Risk factors for methimazole-induced agranulocytosis in Graves' disease: A systematic review and meta-analysis. Clin Endocrinol (Oxf). 2020 Dec;93(6):683-690. doi: 10.1111/cen.14322. Epub 2020 Sep 17. PMID: 32943340.
* He X, Li J, Liu Z, et al. Incidence of antithyroid drug-induced agranulocytosis and hepatotoxicity: A systematic review and meta-analysis. J Clin Endocrinol Metab. 2018 Mar 1;103(3):1022-1031. doi: 10.1210/jc.2017-02013. PMID: 29358245.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.